OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PHG$12.1055

Patrangsit Healthcare Group PCL

Healthcare Facilities & ServicesVerified

Patrangsit Healthcare Group PCL maintains a strong liquidity position, with a current ratio of 4.93 and cash and equivalents amounting to 337,220,660 THB. The company's price-to-book ratio is 1.64, and its return on equity is 0.1399, indicating a solid return on investment for shareholders. In terms of profitability, the company's return on assets of 0.1188 and operating income of 388,030,100 THB reflect a healthy performance. These metrics are in line with the preferred metrics for the Healthcare Facilities & Services industry, suggesting that the company is performing at or above the industry median. The company operates through a single segment, the hospital business, and its revenue is primarily concentrated in Thailand. There is no indication of significant geographic diversification, which may pose a concentration risk if the domestic market experiences downturns. The company's growth trajectory is positive, with a strong operating cash flow of 368,757,280 THB and a free cash flow of 195,661,760 THB. These figures suggest that the company is generating sufficient cash to support operations and potentially fund future growth initiatives. The risk assessment indicates a low level of liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with minimal leverage. Recent events and filings do not indicate any significant changes or risks for the company. The company's financial health appears stable, with no immediate concerns regarding liquidity or dilution.

30-day price · PHG-0.60 (-4.8%)
Low$11.90High$12.70Close$11.90As of12 May, 00:00 UTC
Profile
CompanyPatrangsit Healthcare Group PCL
TickerPHG.BK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Patrangsit Healthcare Group PCL operates as a private hospital in Thailand, providing a range of medical services through its hospitals, including PatRangsit Hospital, PatRangsit 2 Hospital, and PatRangsit Mother and Child Hospital.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a classification confidence of 0.92.

Patrangsit Healthcare Group PCL maintains a strong liquidity position, with a current ratio of 4.93 and cash and equivalents amounting to 337,220,660 THB. The company's price-to-book ratio is 1.64, and its return on equity is 0.1399, indicating a solid return on investment for shareholders. In terms of profitability, the company's return on assets of 0.1188 and operating income of 388,030,100 THB reflect a healthy performance. These metrics are in line with the preferred metrics for the Healthcare Facilities & Services industry, suggesting that the company is performing at or above the industry median. The company operates through a single segment, the hospital business, and its revenue is primarily concentrated in Thailand. There is no indication of significant geographic diversification, which may pose a concentration risk if the domestic market experiences downturns. The company's growth trajectory is positive, with a strong operating cash flow of 368,757,280 THB and a free cash flow of 195,661,760 THB. These figures suggest that the company is generating sufficient cash to support operations and potentially fund future growth initiatives. The risk assessment indicates a low level of liquidity and dilution risk. The company has no immediate filing-based liquidity or dilution flags, and its debt-to-equity ratio is 0.0, suggesting a conservative capital structure with minimal leverage. Recent events and filings do not indicate any significant changes or risks for the company. The company's financial health appears stable, with no immediate concerns regarding liquidity or dilution.
Key takeaways
  • Patrangsit Healthcare Group PCL has a strong liquidity position with a current ratio of 4.93.
  • The company's return on equity of 0.1399 indicates a solid return for shareholders.
  • The company operates through a single segment, the hospital business, with revenue concentrated in Thailand.
  • The company's growth is supported by a strong operating cash flow and free cash flow.
  • The company has a low level of liquidity and dilution risk, with no immediate filing-based flags.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's strong operating income and gross profit suggest stable margins, supported by consistent demand for healthcare services in Thailand.
  • **rd_outlook_rationale**: No specific R&D data is provided, but the company's focus on a broad range of medical services implies ongoing investment in service quality and patient care.
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$2.51B
Gross profit$627.1M
Operating income$388.0M
Net income$309.5M
R&D
SG&A
D&A
SBC
Operating cash flow$368.8M
CapEx-$72.1M
Free cash flow$195.7M
Total assets$2.60B
Total liabilities$392.3M
Total equity$2.21B
Cash & equivalents$337.2M
Long-term debt$7.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$12.10
Market cap$3.63B
Enterprise value$3.30B
P/E11.7
Reported non-GAAP P/E
EV/Revenue1.3
EV/Op income8.5
EV/OCF8.9
P/B1.6
P/Tangible book1.6
Tangible book$2.21B
Net cash$329.7M
Current ratio4.9
Debt/Equity0.0
ROA11.9%
ROE14.0%
Cash conversion1.2%
CapEx/Revenue-2.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricPHGActivity
Op margin15.5%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin12.3%14.7% medp25 11.7% · p75 28.1%below median
Gross margin25.0%19.7% medp25 19.7% · p75 39.8%above median
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-2.9%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity0.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:24 UTC#d3014749
Market quoteclose THB 12.10 · shares 0.30B diluted
no public URL
2026-05-10 12:24 UTC#533564c6
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:27 UTCJob: 284daa0d